Chapter e23

The skin is an essential component of the nonspecific immune system, protecting the host from potential pathogens in the environment. Breaches in this protective barrier thus represent a form of immunocompromise that predisposes a patient to infection. Thermal burns may cause massive destruction of the integument as well as derangements in humoral and cellular immunity, permitting the development of infection caused by environmental opportunists and components of the host's skin flora.

Over the last decade, the estimated incidence of burn injuries in the United States has declined steadily; however, >1 million burn injuries are brought to medical attention each year. Although many burn injuries are minor and require little or no intervention, 50,000 persons are hospitalized for these injuries, 60% of whom require intensive care in a specialized burn center and 20,000 of whom have major burns involving at least 25% of the total body surface area. The majority of burn patients are men. Infants account for ~10% of all reported cases. Scalds, structural fires, and flammable liquids and gases are the major causes of burns, but electrical, chemical, and smoking-related sources are also important. Burns predispose to infection by damaging the protective barrier function of the skin, thus facilitating the entry of pathogenic microorganisms, and by inducing systemic immunosuppression. It is therefore unsurprising that multiorgan failure and infectious complications are the major causes of morbidity and death in serious burn injuries. As many as 10,000 patients in the United States die of burn-related infections each year, and 6 of the top 10 complications recently identified by the American Burn Association's 10-year review are infectious. These 10 most common complications are pneumonia (4.6%), septicemia (2.7%), cellulitis/traumatic injury (2.6%), respiratory failure (2.5%), wound infection (2.2%), other infection (2.0%), renal failure (1.5%), line infection (1.4%), acute respiratory distress syndrome (1.2%), and arrhythmia (1.0) (www.ameriburn.org/2007NBRAnnualReport.pdf).

Loss of the cutaneous barrier facilitates entry of the patient's own flora and of organisms from the hospital environment into a burn wound. Initially, the wound is colonized with gram-positive bacteria from the surrounding tissue, but the number of bacteria grows rapidly beneath the burn eschar, reaching ~8.4 × 103 cfu/g on day 4 after the burn. The avascularity of the eschar, along with the impairment of local immune responses, favors further bacterial colonization and proliferation. By day 7, the wound is colonized with other microbes, including gram-positive bacteria, gram-negative bacteria, and yeasts derived from the gastrointestinal and upper respiratory flora. Invasive infection'localized and/or systemic—occurs when these bacteria penetrate viable tissue. In addition, a role for biofilms has been recognized in experimental animal models of burn-wound infection. (Biofilms are surface-associated communities of bacteria, often embedded in a matrix, that allow the microbes to persist and to resist the effects of host immunity and antimicrobial agents.)

Streptococci and staphylococci were the predominant causes of burn-wound infection in the preantibiotic era and are still important pathogens. With the advent of antimicrobial agents, Pseudomonas aeruginosa became ...

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### AccessMedicine Full Site: One-Year Subscription

Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.